A Minnesota psychedelics task force charged with studying the medical benefits of psilocybin, MDMA and LSD and preparing the state for possible legalization will convene on...
The Washington State Department of Commerce released a document this week recommending how $200 million should be spent to address racial, economic and social disparities created...
For nearly as long as the federal government has classified marijuana as a Schedule I controlled substance, the Food and Drug Administration (FDA) has been evaluating...
Two advocacy coalitions reresenting opposite ends of the political spectrum have joined forces to call for President Joe Biden to remove marijuana from the federal Controlled...
Beginning next month, adults in Connecticut will be able to buy up to half an ounce of marijuana in a single retail transaction—double the state’s current...
Nearly $17 million in Missouri cannabis sales revenue is being routed to programs in the state aimed at veterans health, drug treatment and legal aid. Officials...
A new report looking into how CBD access affects opioid prescriptions concludes that while legalizing CBD may not itself reduce opioid prescribing rates, the ability to...
Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a...
It’s time to end prohibition and instead legalize and regulate all drugs, according to a new Reason Foundation report from a coalition of analysts and advocacy...
Regulators in Minnesota are seeking public input as they begin the process of crafting rules for the state’s new marijuana industry, hoping to hear from “the...
